BiotechTube
Morari Medical

Morari Medical

San Francisco, United States· Est.
morarimedical.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $3.2M

Overview

Morari Medical is a private, commercial-stage medical device company targeting the multi-billion dollar male sexual dysfunction market with its FDA-cleared MOR wearable patch. The device represents a novel, drug-free neuromodulation approach to conditions like premature ejaculation, leveraging app-enabled technology for user control. Founded in 2020, the company is positioned to capitalize on a significant unmet need in sexual wellness, moving beyond traditional pharmaceutical and topical treatments. Its near-term focus is on commercial launch and scaling following regulatory approval.

UrologySexual Health

Technology Platform

App-enabled wearable neuromodulation patch using transcutaneous electrical stimulation to inhibit nerve signals related to the ejaculatory reflex.

Funding History

1
Total raised:$3.2M
Seed$3.2M

Opportunities

The primary opportunity lies in addressing the vast, underserved market of premature ejaculation (affecting ~30% of men globally) with a first-in-class, drug-free, FDA-cleared wearable device.
The broader sexual wellness and performance enhancement market represents an even larger demographic.
The platform technology also offers potential for expansion into adjacent urologic conditions.

Risk Factors

Key risks include commercialization challenges in a sensitive market, slow consumer adoption due to stigma or cost without insurance reimbursement, and future competition from both pharmaceutical and medical device companies.
Regulatory compliance and managing post-market surveillance are ongoing responsibilities.

Competitive Landscape

Morari competes against existing PE treatments including daily/on-demand SSRIs (e.g., dapoxetine, off-label sertraline) and topical anesthetics, which have side-effect and usability drawbacks. It also exists in the broader 'sextech' and wellness device space. Its main competitive advantages are its FDA clearance as a medical device and its novel, drug-free neuromodulation mechanism.

More companies in Digital Health & Biotech SaaS →More companies in United States →